Elixinol CBD Announces Buy-One-Get-One (BOGO) For Holiday Shoppers
DENVER, Nov. 14, 2018 (GLOBE NEWSWIRE) -- The holidays can be a stressful time for holiday shoppers. To ease that frustration, Elixinol, the world’s most trusted CBD brand, is offering Buy-One-Get-One (BOGO) on Elixinol products on elixinol.com exclusively for Black Friday and Cyber Monday.
In addition to BOGO, Elixinol recently announced Free Shipping for all U.S. orders.
“We only do this once per year, but it’s a great opportunity because this is easily the best value in premium CBD,” said Chris Husong, Director of Sales & Marketing for Elixinol.
“Many of our customers view this as an opportunity to introduce Elixinol CBD to friends and family or to stock up for themselves,” he continued.
As part of Elixinol’s “Do-Good, Feel-Good” philosophy, all Elixinol.com purchases throughout the year, including BOGO, donate 5% to a charity of the purchaser’s choice including health, veteran, and hemp non-profits.
All Elixinol and PetReleaf brands are included in this offer, but these include the most popular products available on elixinol.com:
ELIXINOL LIPOSOMES: An Elixinol exclusive. Perfect for executives who need focus and energy throughout the day, water-soluble and great tasting, Elixinol Liposomes are a perfect product to have on the desk.
Elixinol Liposomes have a refreshing, all-natural, citrus flavor, perfect for adding to water or smoothies. It is made from full-spectrum hemp extract without any isolates or synthetic cannabinoids.
Many gift givers also find Elixinol Liposomes are an easy introduction to Elixinol’s CBD products and perfect for parents and grandparents who want to incorporate CBD into their wellness routines.
Elixinol Liposomes are available in 300mg and 1000mg on Elixinol’s website.
ELIXINOL HEMP BALM:Beloved by athletes and runners, in particular, Elixinol’s Hemp balm is a topical full-spectrum CBD application. Whatever your aches and pains, Hemp Balm is on it. Elixinol’s Hemp Balm is 100% plant-based formula and 100% free of synthetic chemicals. It is safe for all skin types and has a pleasant aroma.
NYC Marathon runner, Jessica F., says since incorporating Elixinol Hemp Balm into her training, “I don’t even have to take an ice bath after long training runs any longer.”
For the gym enthusiast, Elixinol Hemp Balm is an easy product to keep in the gym bag for post-workout use.
“My participants are asking for Elixinol Hemp Balm at every station along the route,” says John LaCroix, the producer of the ultra-marathon Human Potential Running Series in Colorado.
Elixinol Hemp Balm is available on Elixinol’s website in 125mg.
PET RELEAF DOG TREATS: For the dog lover in your life, PetReleaf Edibites CBD dog treats make dog owners and their dogs happy. As the only non-Elixinol branded product available for the BOGO offer, PetReleaf CBD dog treats use Elixinol’s premium hemp CBD extract combined with other human-grade ingredients.
Made in small batches and formulated by veterinarians, PetReleaf products are made in the U.S.A.
PetReleaf Edibites CBD Dog Treats are available in Peanut Butter & Banana and Blueberry & Cranberry flavors on Elixinol’s website.
About Elixinol: Colorado-based Elixinol, co-founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and extracting premium-quality hemp, Elixinol also conducts rigorous laboratory testing and quality control. Elixinol distributes hemp-derived CBD products in 40 countries globally including North and South America, throughout Europe, Asia, and the Pacific Region under its own label as well as bulk CBD and wholesale CBD. Elixinol’s parent company EXL ( elixinolglobal.com ) is publicly traded on the Australian Securities Exchange and on the U.S. OTC (ASX:EXL, OTCQX: ELLXF). More information available at Elixinol.com.
Media Contact: Chris HusongElixinol+1 844-804-3504 ext 420 email@example.com
Photos accompanying this announcement are available at: http://www.globenewswire.com/NewsRoom/AttachmentNg/3868bd0f-95b2-405d-8f08-f1d2b7c2fc68http://www.globenewswire.com/NewsRoom/AttachmentNg/172048ea-2f3c-4086-9e75-7a80653cd1b3http://www.globenewswire.com/NewsRoom/AttachmentNg/39dc4149-5a39-4854-93b4-4897c1e46889